Summary model for the c-Jun N-terminal kinase (JNK)/c-Jun/activator protein 1 (AP-1)-mediated signaling pathway in anticancer drug-induced cell death
A summary model for the c-Jun N-terminal kinase (JNK)/c-Jun/activator protein 1 (AP-1)-mediated signaling pathway in anticancer drug-induced cell death. Anticancer drugs that damage DNA and tubulin activate JNK, causing c-Jun/AP-1 to dimerize predominantly with Fra-1 and activate target genes such as Bax/Bak and Fas L, which activate the caspase cascade in an AP-1-dependent pathway leading to apoptotic cell death. JNK phosphorylates and inactivates antiapoptotic proteins such as B-cell lymphoma (Bcl)-2 and Bcl-xL, which in turn activate Bax and cause apoptotic cell death. JNK also activates growth arrest- and DNA damage-inducible gene 153 (Gadd153), which is induced by AP-1-dependent and -independent pathways in endoplasmic reticulum (ER)-mediated cell death. ER stress and p53 induction by anticancer drugs activates Gadd153 and causes ER-mediated cell death. JNK phosphorylates Beclin-1, dissociates from Bcl-2, and induces autophagic cell death. The JNK-mediated upregulation of autophagy-related genes (ATGs) involves the AP-1 transcription factor complex. In response to DNA damage, JNK mediates apoptosis by phosphorylating p53, stabilizing p73, dimerizing p53 and p73, and promoting the expression of proapoptotic target genes such as Bax and Puma. Abbreviations: VBL, vinblastine; PTX, paclitaxel; DTX, docetaxel; UV, ultraviolet; RT, radiation therapy; UPR, unfolded protein response; IRE1, inositol-requiring 1; PERK, protein kinase-like ER kinase; ATF6, activating transcription factor 6; CHOP, CCAAT/enhancer-binding protein homologous protein; DR, death receptor; DISC, death-induced signaling complex; Mcl-1, myeloid cell leukemia 1. This figure was custom-made by Wiley Editing Services based on our freehand drawing
Publication
Impact of Complex Apoptotic Signaling Pathways on Cancer Cell Sensitivity to Therapy (2024) Ryungsa Kim, et al. Cancers (Basel). 2024 Mar;16(5). Figure: F3.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | Beclin-1 | BECLIN1 | ncbigene_synonym | BECN1 | 8678 |
| Homo sapiens | Primates | Bcl-2/Beclin-1 | BCL-2 | ncbigene_synonym | BCL2 | 596 |
| Homo sapiens | Primates | Bcl-2/Beclin-1 | BC2 | ncbigene_synonym | CHMP2A | 27243 |
| Homo sapiens | Primates | Bax | BAX | ncbigene_symbol | BAX | 581 |
| Homo sapiens | Primates | Bax/Bak | BAK | ncbigene_synonym | BAK1 | 578 |
| Homo sapiens | Primates | JNK-dependent | JNK | ncbigene_synonym | MAPK8 | 5599 |
| Homo sapiens | Primates | JNK-dependent | JNK | famplex_relations | MAPK9 | 5601 |
| Homo sapiens | Primates | JNK-dependent | JNK | famplex_relations | MAPK10 | 5602 |
| Homo sapiens | Primates | c-Jun | C-JUN | ncbigene_synonym | JUN | 3725 |
| Homo sapiens | Primates | AP-1 | AP-1 | ncbigene_synonym | FOS | 2353 |
| Homo sapiens | Primates | AP-1 | AP-1 | ncbigene_synonym | FOSB | 2354 |
| Homo sapiens | Primates | AP-1 | AP-1 | ncbigene_synonym | JUNB | 3726 |
| Homo sapiens | Primates | AP-1 | AP-1 | ncbigene_synonym | JUND | 3727 |
| Homo sapiens | Primates | Fas | FAS | ncbigene_symbol | FAS | 355 |
| Homo sapiens | Primates | Fas | FAS | ncbigene_synonym | FASN | 2194 |
| Homo sapiens | Primates | FasL | FASL | ncbigene_synonym | FASLG | 356 |
| Homo sapiens | Primates | Caspase | CASPASE | famplex_relations | CASP1 | 834 |
| Homo sapiens | Primates | Caspase | CASPASE | famplex_relations | CASP2 | 835 |
| Homo sapiens | Primates | Caspase | CASPASE | famplex_relations | CASP4 | 837 |
| Homo sapiens | Primates | Caspase | CASPASE | famplex_relations | CASP5 | 838 |
| Homo sapiens | Primates | Caspase | CASPASE | famplex_relations | CASP6 | 839 |
| Homo sapiens | Primates | Caspase | CASPASE | famplex_relations | CASP8 | 841 |
| Homo sapiens | Primates | Caspase | CASPASE | famplex_relations | CASP9 | 842 |
| Homo sapiens | Primates | Caspase | CASPASE | famplex_relations | CASP10 | 843 |
| Homo sapiens | Primates | Caspase | CASPASE | famplex_relations | CASP12 | 100506742 |
| Homo sapiens | Primates | Caspase | CASPASE | famplex_relations | CASP14 | 23581 |
| Homo sapiens | Primates | Caspase | CASPASE | famplex_relations | CASP3 | 836 |
| Homo sapiens | Primates | Caspase | CASPASE | famplex_relations | CASP7 | 840 |
| Homo sapiens | Primates | Fra-1 | FRA-1 | ncbigene_synonym | FOSL1 | 8061 |
| Homo sapiens | Primates | via | VIA | ncbigene_synonym | SEMA6A | 57556 |
| Homo sapiens | Primates | ATF6 | ATF6 | ncbigene_symbol | ATF6 | 22926 |
| Homo sapiens | Primates | PERK | PERK | ncbigene_synonym | EIF2AK3 | 9451 |
| Homo sapiens | Primates | IRE1/PERK/ATF6signaling | IRE1 | ncbigene_synonym | ERN1 | 2081 |
| Homo sapiens | Primates | p53 | P53 | ncbigene_synonym | TP53 | 7157 |
| Homo sapiens | Primates | p53 | P53 | famplex_relations | TP63 | 8626 |
| Homo sapiens | Primates | p53 | P53 | famplex_relations | TP73 | 7161 |
| Homo sapiens | Primates | p73- | P73 | ncbigene_synonym | ARHGAP24 | 83478 |
| Homo sapiens | Primates | Puma- | PUMA | ncbigene_synonym | BBC3 | 27113 |
| Homo sapiens | Primates | Gadd153 | GADD153 | ncbigene_synonym | DDIT3 | 1649 |
| Homo sapiens | Primates | Bim | BIM | ncbigene_synonym | BCL2L11 | 10018 |
| Homo sapiens | Primates | DR4,5 | DR5 | ncbigene_synonym | TNFRSF10B | 8795 |
| Homo sapiens | Primates | DR4,5 | DR4 | ncbigene_synonym | HLA-DRB4 | 3126 |
| Homo sapiens | Primates | DR4,5 | DR4 | ncbigene_synonym | TNFRSF10A | 8797 |
| Homo sapiens | Primates | Bcl-2/Bcl-xL/Mcl-1/Bcl-W | MCL-1 | ncbigene_synonym | MCL1 | 4170 |
| Homo sapiens | Primates | Bcl-2/Bcl-xL/Mcl-1/Bcl-W | BCL-W | ncbigene_synonym | BCL2L2 | 599 |
| Word | Match | MeSH | Name | ChEBI |
|---|---|---|---|---|
| inhibitors | inhibitors | inhibitor | chebi:35222 | |
| drugs | drugs | chebi:23888 | ||
| DNA | DNA | deoxyribonucleic acids | chebi:16991 | |
| CHOP | ChoP | N,N,N-trimethyl-2-(phosphonooxy)ethanaminium | chebi:18132 |
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|